QED Therapeutics

0 followers

QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. They plan to develop infigratinib in additional FGFR-driven tumor ty... Read more

Industries

Employees

11-50

Links


Org chart

Chief Executive Officer
Collapse
Senior Vice President, Pharmaceutical Development, QED Therapeutics
SVP of Strategy and Operations

Board & advisors

Chairman of the Board
Board Member